Lund Hemodynamic Lab
21 – 30 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension
- Contribution to journal › Article
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
- Contribution to journal › Letter
-
Mark
Plasma VEGF-D and sFLT-1 are potential biomarkers of hemodynamics and congestion in heart failure and following heart transplantation
- Contribution to journal › Article
- 2022
-
Mark
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
- Contribution to journal › Article
-
Mark
Validation of cause of death classification after heart transplantation and cause-specific life expectancy compared to the general population
- Contribution to journal › Article
-
Mark
Bioactive adrenomedullin for assessment of venous congestion in heart failure
- Contribution to journal › Article
-
Mark
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
- Contribution to journal › Article
-
Mark
Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
- Contribution to journal › Article
